Skip to main content
Top
Published in: Malaria Journal 1/2018

Open Access 01-12-2018 | Case report

A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether–lumefantrine treatment

Published in: Malaria Journal | Issue 1/2018

Login to get access

Abstract

Background

Blackwater fever is a complication of malaria infection consisting of a syndrome of febrile intra-vascular haemolysis with severe anaemia and intermittent passage of dark-red to black colour urine. Despite numerous reports and studies of this condition, its pathogenesis remains incompletely understood.

Case presentation

This report describes a case of classic blackwater fever in a returning traveller, without prior history of malaria infection nor usage of anti-malarial prophylaxis, treated with two courses of oral artemether–lumefantrine combination therapy. Unusual persistence of submicroscopic Plasmodium falciparum parasitaemia was detected by PCR for 18 days after initiation of treatment.

Conclusion

To the authors’ knowledge this is the first reported occurrence of a case of blackwater fever associated with prolonged submicroscopic parasitaemia. This unusual case challenges the current knowledge of the pathogenesis of this condition and opens questions that may have important diagnostic and treatment implications.

Literature
  1. Easmon JF. The nature and treatment of blackwater fever with bibliography, notes and temperature charts of cases treated. London: The Government of the Gold Coast Colony; 1884.
  2. Easmon JF. Notes of a case of blackwater fever with remarks (I. The so-called fièvre bilieuse mélanurique or hématurique of French writers). Med Times. 1885;2:277–80.
  3. Bérenger-Féraud LJB. De la fièvre bilieuse mélanurique des pays chauds comparée avec la fièvre jaune. Étude clinique faite au Sénégal. Paris A Delahaye. 1874.
  4. Bruce-Chwatt LJ, de Zulueta J. The rise and fall of malaria in Europe: a historico-epidemiological study. Oxford: Oxford University Press; 1980.
  5. Van den Ende J, Coppens G, Verstraeten T, Haegenborgh Van, Depraetere K, Van Gompel A, et al. Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health. 1998;3:632–9.View ArticlePubMed
  6. Kouzis A. Quelques mots sur les fièvres paludéennes d’après les anciens médecins Grecs. Atti Soc Studi Malar. 1908;9:81–94.
  7. Plehn A. Neue Untersuchungen über die Entstehungsweise des Schwarzwassenfiebers. Arch Schiff Tropen Hyg. 1920;24:321–6.
  8. Katongole-Mbidde E, Banura C, Kizito A. Blackwater fever caused by Plasmodium vivax infection in the acquired immune deficiency syndrome. Br Med J. 1988;296:827.View Article
  9. Barber BE, William T, Grigg MJ, Menon J, Auburn S, Marfurt J, et al. A prospective comparative study of knowlesi, falciparum and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and P. vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis. 2013;56:383–97.View ArticlePubMed
  10. Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM. Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria. Malar J. 2016;15:462.View ArticlePubMedPubMed Central
  11. Chau TTH, Day NP, Van Chuong L, Mai NTH, Loc PP, Phu NH, et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis. 1996;23:1274–81.View Article
  12. Bisoffi Z, Marocco S, Monteiro G, Marsiaj M. Acute intravascular haemolysis (blackwater fever) after antimalarial treatment. Trop Med Int Health. 1999;4:72–3.View ArticlePubMed
  13. Bruneel F, Gachot B, Wolff M, Régnier B, Danis M, Vachon F. Resurgence of blackwater fever in long term European expatriates in Africa: report of 21 cases and review. Clin Infect Dis. 2001;32:1133–40.View ArticlePubMed
  14. Rogier C, Imbert P, Tall A, Sokhna C, Spiegel A, Trape J-F. Epidemiological and clinical aspects of blackwater fever among African children suffering frequent malaria attacks. Trans R Soc Trop Med Hyg. 2003;97:193–7.View ArticlePubMed
  15. Georges CRP. Blackwater fever: the rise and fall of an exotic disease. J Nephrol. 2009;22(Suppl 14):120–8.
  16. Stephens JWW. Blackwater fever: a historical survey and summary of observations made over a century. London: University Press of Liverpool; 1937.
  17. Rivera N, Romero SE, Menchaca A, Zepeda A, García LE, Salas G, et al. Blackwater fever like in murine malaria. Parasitol Res. 2013;112:1021–9.View ArticlePubMed
  18. Carson PE, Larkin Flanagan C, Ickes CE, Alving AS. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science. 1956;124:484–5.View ArticlePubMed
  19. Meshnick SR, Yang Y, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob Agents Chemother. 1993;37:1108–14.View ArticlePubMedPubMed Central
  20. Aloni NM, Nsangu M, Kunuanumua T, Muanda TF. Hémolyse intravasculaire après prise d’artéméther-lumefantrine. Bull Soc Path Exot. 2010;103:296–8.View Article
  21. Lon C, Spring M, Sok S, Chann S, Bun R, Ittiverakul M, et al. Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin–piperaquine. Malar J. 2014;13:96.View ArticlePubMedPubMed Central
  22. Price R, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547–55.View ArticlePubMed
  23. Dondorp A, Nosten F, Stepniewska K, Day N, White N. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366:717–25.View ArticlePubMed
  24. Dondorp AM, Fanello CI, Hendriksen ICE, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376:1647–57.View ArticlePubMedPubMed Central
  25. Medicine for Malaria Venture. Experts group meeting on delayed anaemia following treatment with injectable artesunate. Vienna: Medicine for Malaria Venture; 2013.
  26. Paczkowski MM, Landman KL, Arguin PM. Update on causes of delayed hemolysis after parenteral artesunate therapy for malaria—United States, 2008–2013. MMWR. 2014;63:753–5.PubMed
  27. Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, et al. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood. 2014;124:167–75.View ArticlePubMedPubMed Central
  28. Vachon F, Fajac I, Gachot B, Coulaud JP, Charmot G. Halofantrine and acute intravascular haemolysis. Lancet. 1992;340:909–10.View ArticlePubMed
  29. Mojon M, Wallon M, Gravey A, Peaud PY, Sartre J, Peyron F. Intravascular haemolysis following halofantrine intake. Trans R Soc Trop Med Hyg. 1994;88:91.View ArticlePubMed
  30. Orlando G, Isabella L, Atzori C, Cargnel A. Blackwater fever after halofantrine. Lancet. 1996;347:1408–9.View ArticlePubMed
  31. Nozais JP, Raynaud de Lage G, Gentilini M. Un cas probable de fièvre bilieuse hémoglobinurique après prise de méfloquine à dose prophylactique. Méd Mal Infect. 1992;22:407–9.View Article
  32. Danis M, Nozais JP, Paris L, Robert C, Katlama C, Gentilini M, et al. Fièvre bilieuse hémoglobinurique après prise de méfloquine. 3 observations. Presse Méd. 1993;22:80.PubMed
  33. Mérat S, Lambert E, Vincenti-Rouquette I, Gidenne S, Rousseau JM, Brinquin L. Case report: combination artemether–lumefantrine and haemolytic anaemia following a malarial attack. Trans R Soc Trop Med Hyg. 2003;97:433–4.View ArticlePubMed
  34. Daubrey-Potey T, Die-Kacou H, Kamagate M, Vamy M, Balayssac M, Yavo JC. Fièvre bilieuse hémoglobinurique au cours du traitement antipaludique à Abidjan: à propos de 41 cas. Bull Soc Path Exot. 2004;97:325–8.
  35. Findlay GM. Blackwater fever in West-Africa, 1941–45. II. Blackwater fever in African military personnel. Ann Trop Med Parasitol. 1949;43:213–24.View ArticlePubMed
  36. Brown SG. A fatal case of blackwater fever associated with ingestion of nivaquine. Trans R Soc Trop Med Hyg. 1954;48:250–2.View Article
  37. Bruce-Chwatt LJ. Quinine and the mystery of blackwater fever. Acta Leidensia. 1987;55:181–96.PubMed
  38. World Health Organization. Division of control of tropical diseases: severe and complicated malaria. Trans R Soc Trop Med Hyg. 1990;84(S2):1–65.View Article
  39. WHO. Basic malaria microscopy—Part 1. Learner’s guide. 2nd ed. Geneva: World Health Organization; 2010.
  40. Chavatte J-M, Tan SBH, Snounou G, Lin RTPV. Molecular characterization of misidentified Plasmodium ovale imported cases in Singapore. Malar J. 2015;14:454.View ArticlePubMedPubMed Central
  41. Safeuki I, Millet P, Boucher S, Melinard L, Fregeville F, Receveur M-C, et al. Evaluation of FRET real-time PCR assay for rapid detection and differentiation of Plasmodium species in returning travellers and migrants. Malar J. 2008;7:70.View Article
  42. Snounou G, Singh B. Nested PCR analysis of Plasmodium parasites. Meth Mol Med. 2002;72:189–203.
  43. Imwong M, Tanomsing N, Pukrittayakamee S, Day NP, White NJ, Snounou G. Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect Plasmodium knowlesi. J Clin Microbiol. 2009;47:4173–5.View ArticlePubMedPubMed Central
  44. Felger I, Snounou G. Recommended genotyping procedures (RGPs) to identify parasite populations. Geneva: Medicine for Malaria Venture and World Health Organization; 2008.
  45. Hanron AE, Billman ZP, Seilie AM, Olsen TM, Fishbaugher M, Chang M, et al. Multiplex, DNase-free one-step reverse transcription PCR for Plasmodium 18S rRNA and spliced gametocyte-specific mRNAs. Malar J. 2017;16:208.View ArticlePubMedPubMed Central
  46. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283–92.View ArticlePubMed
  47. Ndao M, Bandyayera E, Kokoskin E, Gyorkos TW, MacLean JD, Ward BJ. Comparison of blood smear, antigen detection, and nested-PCR methods for screening refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada. J Clin Microbiol. 2004;42:2694–700.View ArticlePubMedPubMed Central
  48. Johnston SP, Pieniazek NJ, Xayavong MV, Slemenda SB, Wilkins PP, da Silva AJ. PCR as a confirmatory technique for laboratory diagnosis of malaria. J Clin Microbiol. 2006;44:1087–9.View ArticlePubMedPubMed Central
  49. Coleman RE, Sattabongkot J, Promstaporm S, Maneechai N, Tippayachai B, Kengluecha A, et al. Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Malar J. 2006;5:121.View ArticlePubMedPubMed Central
  50. Wang B, Han SS, Cho C, Han JH, Cheng Y, Lee SK, et al. Comparison of microscopy, nested-PCR, and Real-Time-PCR assays using high-throughput screening of pooled samples for diagnosis of malaria in asymptomatic carriers from areas of endemicity in Myanmar. J Clin Microbiol. 2014;52:1838–45.View ArticlePubMedPubMed Central
  51. Laveran A. Traité du Paludisme. Paris: Masson; 1898. p. 361–9.
  52. Maegraith B. Blackwater fever modern theories. Trop Dis Bull. 1946;43:801–9.PubMed
  53. Lefrou G. Considérations sur l’étiologie de la fièvre bilieuse hémoglobinurique. A propos de 123 cas observés au Soudan. Bull Soc Path Exot. 1948;41:176–87.
  54. Plewes K, Haider MS, Kingston HWF, Yeo TW, Ghose A, Hossain MA, et al. Severe falciparum malaria treated with artesunate complicated by delayed onset haemolysis and acute kidney injury. Malar J. 2015;14:246.View ArticlePubMedPubMed Central
  55. Hue NT, Charlieu JP, Chau TT, Day N, Farrar JJ, Hien TT, et al. Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population. Malar J. 2009;8:152.View ArticlePubMedPubMed Central
  56. Chotivanich K, Udomsangpetch R, McGready R, Proux S, Newton P, Pukrittayakamee S, et al. Central role of the spleen in malaria parasite clearance. J Infect Dis. 2002;185:1538–41.View ArticlePubMed
  57. Beshir KB, Sutherland CJ, Sawa P, Drakeley CJ, Okell L, Mweresa CK, et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. J Infect Dis. 2013;208:2017–24.View ArticlePubMedPubMed Central
  58. Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, et al. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia. Malar J. 2013;12:403.View ArticlePubMedPubMed Central
  59. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether–lumefantrine and dihydroartemisinin–piperaquine: a randomized trial. J Infect Dis. 2013;207:1637–45.View ArticlePubMed
  60. Dinko B, Oguike MC, Larbi JA, Bousema T, Sutherland CJ. Persistent detection of Plasmodium falciparum, P. malariae, P. ovale curtisi and P. ovale wallikeri after ACT treatment of asymptomatic Ghanaian school-children. Int J Parasitol Drugs Drug Resist. 2013;3:45–50.View ArticlePubMedPubMed Central
  61. Betson M, Sousa-Figueiredo JC, Atuhaire A, Arinaitwe M, Adriko M, Mwesigwa G, et al. Detection of persistent Plasmodium spp. infections in Ugandan children after artemether–lumefantrine treatment. Parasitology. 2014;141:1880–90.View ArticlePubMedPubMed Central
  62. Chang HH, Meibalan E, Zelin J, Daniels R, Eziefula AC, Meyer EC, et al. Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda. Sci Rep. 2016;6:26330.View ArticlePubMedPubMed Central
  63. Jarra W, Snounou G. Only viable parasites are detected by PCR following clearance of rodent malarial infections by drug treatment or immune responses. Infect Immun. 1998;66:3783–7.PubMedPubMed Central
  64. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001;183:1254–9.View ArticlePubMed
  65. Four Artemisinin-Based Combinations Study Group. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011;8:e1001119.View Article
  66. Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q. Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis. 2010;202:1362–8.View ArticlePubMedPubMed Central
  67. Klonis N, Xie SC, McCaw JM, Crespo-Ortiz MP, Zaloumis SG, Simpson JA, et al. Altered temporal response of malaria parasites determines differential sensitivity to artemisinin. Proc Natl Acad Sci USA. 2013;110:5157–62.View ArticlePubMedPubMed Central
  68. Kaur H, Clarke S, Lalani M, Phanouvong S, Guérin P, McLoughlin A, et al. Fake anti-malarials: start with the facts. Malar J. 2016;15:86.View ArticlePubMedPubMed Central
  69. Olupot-Olupot P, Engoru C, Uyoga S, Muhindo R, Macharia A, Kiguli S, et al. High frequency of blackwater fever among children presenting to hospital with severe febrile illnesses in Eastern Uganda. Clin Infect Dis. 2017;64:939–46.View ArticlePubMed
Metadata
Title
A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemether–lumefantrine treatment
Publication date
01-12-2018
Published in
Malaria Journal / Issue 1/2018
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-018-2180-1

Other articles of this Issue 1/2018

Malaria Journal 1/2018 Go to the issue